Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Radiation therapy and cis-diammine-dichloroplatinum (II) in transplantable and primary murine bladder cancer

Conference · · Int. J. Radiat. Oncol., Biol. Phys.; (United States)
OSTI ID:5331837
Preoperative radiation improves survival in advanced bladder cancer but the high failure rate, primarily due to distant metastases, suggests a need for adjuvant chemotherapy. The optimal drug might exhibit an additive effect with radiotherapy. Transitional cell carcinoma (TCC) induced in mice by FANFT closely resembles the human counterpart, and both primary and transplanted tumors were used to evaluate the possible additive effect of cis DDP and cyclophosphamide (CY), two drugs with activity in TCC, with radiation. One hundred C3H/He mice had 5 x 10/sup 4/ TCC cells placed in their right hind limbs and randomized into a control (20) and 8 treatment groups (10); 3600 rad, 3600 rad + CY, 3600 rad + cis DDP, 1500 rad + cis DDP, 1500 rad + CY, CY, and cis DDP. Chemotherapy was initiated on day 7 and continued every week x 3. Radiation, in 250 rad or 600 rad fractions, was given biweekly to the tumor bearing limb using a CO/sub 60/ source. 3600 rad alone produced 60% cures with a significant reduction in average tumor diameter (p < 0.001). 3600 rad + cis DDP achieved 78% cures, the best regimen. Therapy of palpable tumors yielded similar results--ave. tumor diameter (D-38) for controls 16.5, 3000 rad--10.6 (p < 0.001), cis DDP--10.2, CY + 1600 rad--8.1, cis DDP + 300 rad--6.2. Cis DDP + 3000 rad was significantly better than cis DDP or 3000 rad alone. One hundred fifty mice ingesting FANFT for 11 months were randomized into 7 groups and subjected to the same regimens to evaluate the effect on primary tumors. The greatest reduction in tumor volume was in mice receiving 1500 rad + cis DDP (mean bladder weight, 29.68 vs. controls 53.57, p < 0.005). These results consistently suggest cooperation between irradiation and cis DDP. Adjuvant cis DDP for invasive bladder cancer might be maximized by initiation with preoperative radiotherapy. Our initial clinical data with cis DDP + irradiation in advanced TCC are encouraging.
Research Organization:
Univ. of Tennessee, Memphis
OSTI ID:
5331837
Conference Information:
Journal Name: Int. J. Radiat. Oncol., Biol. Phys.; (United States) Journal Volume: 5:8
Country of Publication:
United States
Language:
English

Similar Records

Methionine Adenosyltransferase 1a (MAT1A) Enhances Cell Survival During Chemotherapy Treatment and is Associated with Drug Resistance in Bladder Cancer PDX Mice
Journal Article · Tue Oct 08 20:00:00 EDT 2019 · International Journal of Molecular Sciences (Online) · OSTI ID:1698296

Preliminary report of a cooperative randomized study for the treatment of localized small cell lung carcinoma
Conference · Sat Sep 01 00:00:00 EDT 1979 · Int. J. Radiat. Oncol., Biol. Phys.; (United States) · OSTI ID:5339685